Ruxolitnib Based Treatment in Myeloproliferative Neoplasm

Speaker
Haifa K. Al Ali
Category:
Myelofibrosis

Speaker: Dr. Haifa K. Al Ali

Affiliations: Senior Consultant of Hematology & Internal Oncology, University of Halle, Germany

 

This topic was presented during the Emirates Society of Haematology virtual educational series hosted in 2020.

1
Ruxolitnib Based Treatment in Myeloproliferative Neoplasm
37 minutes

Speaker: Dr. Haifa K. Al-Ali

Affiliations: Senior Consultant of Hematology & Internal Oncology, University of Halle, Germany

 

This topic was presented during the Emirates Society of Haematology virtual educational series hosted in 2020.

Add to Wishlist
Enroll course
Enrolled: 10 students
Presentations: 1
Video: 37 minutes
eaccme

Accreditation Statement

The Hematology Live Online Education, made available on https://hematologylive.online/ and organized by Meeting Minds Experts, is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists.

 

Each medical specialist should claim only those credits that he/she actually spent in the educational activity. The EACCME is an institution of the European Union of Medical Specialists (UEMS). Only those e-learning materials that are displayed on the UEMSEACCME website have formally been accredited.

 

Through an agreement between the European Union of Medical Specialists (UEMS) and the American Medical Association (AMA), physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.